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Figure 1 was printed incorrectly. The correct ﬁgure and legend are printed below.FIGURE 1 Kaplan-Meier Curves for the Comparison Between BVS and Either EES or BMS
(A) Kaplan-Meier event curves comparing bioresorbable vascular scaffold (BVS) and everolimus-eluting stents (EES) for the composite device-
oriented endpoint (DOCE) of cardiac death, target vessel myocardial infarction, and target lesion revascularization. (B)Kaplan-Meier event curves
comparing BVS and EES for deﬁnite/probable device thrombosis. (C) Kaplan-Meier event curves comparing BVS and bare-metal stents (BMS) for
the composite DOCE of cardiac death, target vessel myocardial infarction, and target lesion revascularization. (D) Kaplan-Meier event curves
comparing BVS and BMS for the deﬁnite/probable device thrombosis. The dotted line on the vertical axis indicates the 30-day time point.We apologize for this error.http://dx.doi.org/10.1016/j.jcin.2015.01.005
